Covid-19 roundup: Germany puts J&J on the hotseat for vaccine backorder; Top EMA official suggests forgoing AstraZeneca shot
Shortly after it was announced that the FDA has required J&J to discard tens of millions of Covid-19 vaccines that were contaminated at an embattled Emergent plant in Baltimore, MD, Germany has demanded that the company deliver 6.5 million doses to make up for a shortfall, Reuters reported.
The FDA said Friday that two batches of the drug substance used in J&J’s jab would be released from quarantine after millions of doses were held from distribution at the Emergent site. While that frees up about 10 million doses, The New York Times reported Friday morning another 60 million doses were ordered to be tossed out.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.